Navigation Links
Life Technologies to Launch Ion 318 Chip in Second Half of 2011 with 1Gb of Data Output
Date:2/23/2011

ents and low-cost detection.  The Ion 318 will also leverage four decades of exponential improvement in semiconductor technology, also known as Moore's Law.  This enables the Ion 318 to be priced the same as the Ion 316, even while delivering a 50-fold reduction in sequencing cost – less than a year after the Ion 314 launch.  

SpeedBecause of its simple and flexible workflow, the Ion PGM enables parallel processing of 8 samples per operator, which allows researchers to go from sample to result in less than one day, making it the fastest long read sequencers on the market.  Ion 318 chips will continue to offer incredible sequencing speeds, while delivering up to 1Gb of highly accurate sequence.

The Ion Personal Genome Machine sequencer is for research use only.  Not for use in diagnostic procedures.

About Life TechnologiesLife Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition.  Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better.  Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics.  The company manufactures both molecular diagnostic and research use only products.  Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, Gibco, Ambion, Molecular Probes and Taqman products.  Life Technologies had sales of $3.6 billion in 2010, ha
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
3. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
4. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
5. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
8. Senesco Technologies Initiates Preclinical Studies for Cancer Target
9. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
10. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
11. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  Synereca Pharmaceutics, ... novel orally active drugs that restore or ... today a $1.4 million convertible debt financing. ... life sciences accelerator Accele Biopharma, Inc., led ... a nationally recognized private not-for-profit corporation focused ...
(Date:9/16/2014)... , Sept. 16, 2014  DNAtrix, Inc., ... the first patient was treated with the company,s ... gamma interferon in a randomized, multicenter, open-label Phase ... "DNAtrix, in collaboration with leading neurosurgeons and ... the initiation of our randomized Phase Ib study ...
(Date:9/16/2014)... 2014  Relmada Therapeutics, Inc., (OTCBB: RLMD), a clinical-stage ... pain, announced today that it has entered into an ... a series of animal studies for levorphanol, the active ... form of levorphanol.  Gavril Pasternak, MD, PhD, of MSKCC ... Dr. Pasternak said, "Levorphanol is a unique opioid ...
Breaking Medicine Technology:Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 3Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 4DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3
... Ladin, director of the Pew Health Group,s Antibiotics ... the bipartisan, bicameral Generating Antibiotic Incentives Now (GAIN) ... and Sen. Bob Corker (R-Tenn.).  The bill is ... to incentivize the creation of new antibiotics to ...
... Oct. 19, 2011 The maker of ... aid with a proprietary formula, has succeeded in protecting ... according to the company president, Holly Rosenthal. Under the ... Inc., maker of MidNite Sleep Remedy, and Contract Pharmacal ...
Cached Medicine Technology:Popular Sleep Supplement Brand Settles Patent Infringement Suit Against Store Brand Manufacturer 2
(Date:9/16/2014)... Hospital announced today it is teaming up with the ... the Presenting Sponsor of the 2014-15 and 2015-16 seasons, ... partner. As the Presenting Sponsor for the next two ... inclusion on all Lightning advertising campaigns and materials throughout ... sponsorship partner of the Lightning since 2011, and it ...
(Date:9/16/2014)... of dairy food may reduce the risk of heart ... have not traditionally formed part of the diet. ... Emeritus Professor Mark Wahlqvist from Monash University,s Department of ... considered the role increased consumption of dairy foods had ... , "In a dominantly Chinese food culture, unaccustomed ...
(Date:9/16/2014)... who have had children (parous women) appear to ... breast cancer, the subtype that carries a higher ... of African ancestry. A similar relationship was ... between childbearing and increased risk of estrogen receptor-negative ... the women who had never breastfed. These findings, ...
(Date:9/16/2014)... have developed a new cocktail that is highly ... pluripotent stem cells. , Regenerative medicine is a ... lost or damaged cells, tissues or organs through ... embryos can trigger ethical concerns, a good solution ... state using a combination of reprogramming factors. ...
(Date:9/16/2014)... Terminsurancevirginia.com has released a new blog ... life insurance for obese clients. , Obese clients ... quotes. It is unlikely for applicants to be denied ... life insurance costs. , Having life insurance is ... Life insurance is available as temporary or permanent coverage ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Teams up with the Tampa Bay Lightning as the New Presenting Sponsor of the 2014-15 and 2015-16 Lightning Seasons 2Health News:Florida Hospital Teams up with the Tampa Bay Lightning as the New Presenting Sponsor of the 2014-15 and 2015-16 Lightning Seasons 3Health News:A heart-felt need for dairy food 2Health News:Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk 2Health News:Scientists create therapy-grade stem cells using new cocktail to reprogram adult cells 2Health News:Obese Clients Can Find Affordable No Exam Term Life Insurance at Terminsurancevirginia.com! 2
... HealthDay Reporter , MONDAY, Feb. 7 (HealthDay News) -- ... may be less likely to develop a tough-to-treat brain ... It,s not clear how this knowledge might improve prevention ... said the findings pave the way for further research. ...
... Feb. 7 (HealthDay News) -- The number of Americans ... economy, statistics released Monday suggest. Last year, there ... country, up five percent from 2009, the American Society ... cosmetic surgical procedures and 11.6 cosmetic minimally-invasive procedures. The ...
... State for Research and Emilio Botn, president of ... Finantial City (located in Boadilla del Monte) the ... included in PESA (Progression of Early Subclinical Atherosclerosis) ... Center for Cardiovascular Research (CNIC) and Grupo Santander ...
... radiation from cardiac imaging and other procedures after a ... cancer, found a new study published in CMAJ ... only) http://www.cmaj.ca/embargo/cmaj100463.pdf . The use of procedures ... angiography and nuclear scans, is increasing which has led ...
... Geneva, Switzerland. Following the publication of several media reports ... grants financed by the Global Fund to Fight AIDS, ... all donors and governments to continue their funding. ... instrument which attracts, manages and disburses resources to prevent ...
... diseases. Gene therapy direct replacement of mutant genes by ... defects. Now a research team based at the Medical Center ... Carsten Rudolph, has taken a new approach that avoids DNA ... modification of mRNAs (the metabolically active molecules derived from genomic ...
Cached Medicine News:Health News:Allergies Linked to Lower Brain Cancer Rate in Study 2Health News:Allergies Linked to Lower Brain Cancer Rate in Study 3Health News:As Economy Picks Up, So Do Number of Nips & Tucks 2Health News:CNIC and Grupo Santander present a new venue for imaging tests included in PESA study 2Health News:CNIC and Grupo Santander present a new venue for imaging tests included in PESA study 3Health News:Risk of cancer increases with exposure to low-dose radiation 2Health News:Media reports ignore that Global Fund resources deliver tremendous results in the fight against AIDS 2Health News:Save messengers -- modified mRNAs open up new therapeutic possibilities 2
... best value in high performance electronic pipetting!, ... design reduce hand fatigue and strain , ... ejector , Color coding for easy volume ... greater performance use Hamilton AdvanTip Low Retention ...
... The total ergonomic solution and best value ... feather touch action and ultra lightweight design ... ejection with long, lever tip ejector, Color ... tips or for greater performance use Hamilton ...
... is a major step forward in ... handling system - with one universal ... modules. All five single channel and ... one handle. The lightweight handle is ...
... a system that measures the sedimentation ... rate may be relevant as input ... rate is measured in a batch ... in high-volume settings such as hospitals ...
Medicine Products: